The FDA has granted fast track designation (FTD) to LBL-034, an investigational GPRC5D/CD3 bispecific T-cell engager (BiTE), for patients with relapsed/refractory multiple myeloma (R/R MM).

Apogee Therapeutics (APGE) leverages IL-13 pathway optimization to enable less frequent dosing, targeting a leadership shift ...

Jeff Blashill knew that pairing two inexperienced defensemen together wouldn't be perfect, but Levshunov and Kaiser are learning together.

Two dynamics are fundamentally reshaping the structure and functioning of the American government. The first, which is quite well known, is Congress’s decline. The second, perhaps somewhat less ...

The judge overseeing the trial of a former Uvalde school district police officer rejected a defense motion to declare a mistrial on Wednesday afternoon. Judge Sid Harle ruled the prosecution had not ...

The extraordinary criminal case against deposed Venezuelan President Nicolás Maduro is headed before a 92-year-old judge with a stubborn streak and an often unorthodox approach to running his ...

The timing format for the stage 1 team time trial at the 2026 Tour de France in Barcelona has raised questions from Visma-Lease a Bike's CEO, with it following the new TTT format seen in Paris-Nice in ...

A hormone-free pill, called YCT-529, that temporarily stops sperm production by blocking a vitamin A metabolite has just concluded its first safety trial in humans, getting a step closer to increasing ...

Pay attention. The importance of work-life balance is growing. Employees want more flexibility in their work, better stress management, less burnout and improved delineations between their work and ...